Trial NCT00609765

View at ClinicalTrials.gov 
Org. Study IDs: MCC-14961
Secondary IDs: AVF3915s

Last trial update was posted on 2017-03-23

MeSH Interventions

Bevacizumab Dexamethasone Doxorubicin Fluorouracil Ondansetron Streptozocin

MeSH Conditions

Endocrine Gland Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

Development of new chemotherapy standard of care for treatment rendered the trial obsolete.

Limitations And Caveats

This trial only enrolled one patient and was closed because of development of a new chemotherapy standard of care for treatment of this cancer which we felt rendered the trial obsolete. The trial was open for only 7 months.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID